FDA Grants Fast Approval for Eli Lilly's Weight Loss Drug
The U.S. Food and Drug Administration (FDA) has granted fast approval for a new drug from Eli Lilly aimed at addressing obesity. This decision comes as many countries face rising obesity rates among their populations, raising significant public health concerns.